Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jan 29;3(1):vdab019. doi: 10.1093/noajnl/vdab019

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 1. — [¹⁸F]-FDHT uptake in high-grade gliomas. (I) MRI and (II) PET (registered with post-op CT/MRI) transaxial slices showing (A) high (patient #6), and (B) no (patient #3, gliomatosis cerebri) [¹⁸F]-FDHT uptake on static PET images acquired about 60 min after radiopharmaceutical injection. Blue and red VOIs represent respectively the tumor and biopsy/surgery area on MRI and PET slices. (III) Time-activity curves in terms of SUVmax corresponding to the biopsy/surgery area and normal ipsi- and contralateral brain. The color scale next to each PET image represents the SUV in units of g/mL.